Preclinical Development of New Tetrahydrofuran Derivatives Targeting the Sigma-1 Chaperone Protein
- ANAVEX® Life Sciences Corp.
- Jul 15, 2011
- 1 min read
Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France
Tangui Maurice, Vanessa Villard, Johann Meunier, Valentine Lahmy, Emeline Keller and Alexandre Vamvakides